Skip to main content

Table 2 Baseline clinical characteristics of study eyes.

From: Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study

Characteristic

Study eye

Best-corrected VA (logMAR)

 

   N

73

   Mean (SD)

0.62 (0.24)

   Median (range)

0.54 (-0.18 -- 1.00)

Time from NV-AMD diagnosis to baseline, months

 

   N

73

   Mean (SD)

2.4 (5.9)

   Median (range)

0 (0 -- 31)

Angiographic subtype, n (%)

 

   Minimally classic

4 (5.5)

   Occult

55 (75.3)

   Predominantly classic

11 (15.1)

   Missing

3 (4.1)

Lesion size (disc area), n (%)

 

   < 2

26 (35.6)

   ≥ 2 and < 4

22 (30.1)

   ≥ 4

11 (15.1)

   Missing

14 (19.2)

Lesion location, n (%)

 

   Subfoveal

60 (82.2)

   Extrafoveal

1 (1.4)

   Juxtafoveal

6 (8.2)

   Missing

6 (8.2)

Pigment epithelial detachment, n (%)

 

   Absent

46 (63.0)

   Present

16 (21.9)

   Missing

11 (15.1)

Retinal angiomatous proliferation, n (%)

 

   Absent

58 (79.5)

   Present

1 (1.4)

   Missing

14 (19.2)

Cystoid macular oedema, n (%)

 

   Absent

52 (71.2)

   Present

7 (9.6)

   Missing

14 (19.2)

Fibrosis, n (%)

 

   Absent

57 (78.1)

   Present

3 (4.1)

   Missing

13 (17.8)

Geographic atrophy, n (%)

 

   Absent

54 (74.0)

   Present

10 (13.7)

   Missing

9 (12.3)

Presence of blood, n (%)

 

   Yes

25 (34.2)

   No

43 (58.9)

   Missing

5 (6.8)

Estimated percentage of lesion with blood, n (%)

 

   ≤ 50%

12 (16.4)

   > 50%

3 (4.1)

   Missing

58 (79.5)

  1. NV-AMD = neovascular age-related macular degeneration; SD = standard deviation; VA = visual acuity.